Agenda
16:00-16:10 Welcome & Introduction to the meeting
Dr. Carlos Núñez, Head of Urology at MD Anderson Madrid, Spain
Dr. Enrique Grande, Head of Oncology at MD Anderson Madrid, Spain
16:10-16:30 Innovative techniques for less invasive Nephrectomy
Dr. Antonio Alcaraz, Head of Hospital Clinic Barcelona, Spain
16:30-17:00 What have SURTIME and CARMENA trials changed in our real practice?
Dr. Axel Bex, Royal Free Hospital, London and The Netherlands Cancer Institute, Netherlands
17:00-17:30 ROUND TABLE Led by:
Dr. Eldiberto Fernández, San Rafael Hospital, Spain
Dr. Juan Ignacio Martínez Salamanca, Puerta del Hierro Hospital, Spain
17:30-18:00 The earthquake of data in first-line treatment of metastatic RCC. Can we do a comprehensive summary?
Dr. Javier Puente, Clínico San Carlos Hospital, Spain
18:00-18:30 ESMO 2019 guidelines on mRCC and beyond: challenges to be faced in the short term
Dr. Bernard Escudier, Gustave Roussy Institute, France
18:30-19:00 ROUND TABLE Led by:
Dr. José Ángel Arranz, MD Anderson Madrid, Spain
Dra. Icíar García Carbonero, Virgen de la Salud Toledo Hospital, Spain
19:00-19:10 Closing remarks
Dr. Carlos Núñez, Head of Urology at MD Anderson Madrid, Spain
Dr. Enrique Grande, Head of Oncology at MD Anderson Madrid, Spain
Para más información, info@fundacionmdanderson.es